Implications of arrhythmias and prevention of sudden death in hypertrophic cardiomyopathy

Ann Noninvasive Electrocardiol. 2007 Apr;12(2):171-80. doi: 10.1111/j.1542-474X.2007.00157.x.
No abstract available

Publication types

  • Research Support, U.S. Gov't, Non-P.H.S.
  • Review

MeSH terms

  • Adrenergic beta-Antagonists / therapeutic use
  • Anti-Arrhythmia Agents / therapeutic use
  • Arrhythmias, Cardiac / complications*
  • Arrhythmias, Cardiac / physiopathology
  • Arrhythmias, Cardiac / therapy*
  • Cardiomyopathy, Hypertrophic / complications*
  • Cardiomyopathy, Hypertrophic / physiopathology
  • Cardiomyopathy, Hypertrophic / therapy*
  • Death, Sudden, Cardiac / etiology
  • Death, Sudden, Cardiac / prevention & control*
  • Defibrillators, Implantable*
  • Electrocardiography
  • Electrocardiography, Ambulatory
  • Humans
  • Risk Assessment

Substances

  • Adrenergic beta-Antagonists
  • Anti-Arrhythmia Agents